Autism Spectrum Disorder Clinical Trials in Boston, Massachusetts

5 studies are recruiting for autism spectrum disorder in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients

   The purpose of this study is to evaluate the effectiveness of the behavior analytic intervention in reducing the number of challenging behaviors exhibited by patients with Autism Spectrum Disorder (ASD) while increasing compliance with needle-related simulations and procedures. A second purpose is …

   Stage

   Not phased

   Ages

   3 and older

   Site

   Boston Medical Center, Boston, Massachusetts

   Run by

   Boston Medical Center

   See if you can join NCT06712784 on ClinicalTrials.gov

2. Speech Treatment for Minimally Verbal Children With ASD and CAS

   Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with…

   Stage

   Not phased

   Ages

   5 to 18

   Site

   MGH Institute of Health Professions, Boston, Massachusetts

   Run by

   MGH Institute of Health Professions

   See if you can join NCT05066178 on ClinicalTrials.gov

3. The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

   The investigators are conducting a 10-week brain imaging and medication study. They are doing the research to study the response of Attention-Deficit/ Hyperactivity Disorder (ADHD) in youth with Autism Spectrum Disorder (ASD) on extended-release formulation of mixed amphetamine salts (MAS) (also kn…

   Stage

   Phase 4

   Ages

   8 to 18

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Run by

   Gagan Joshi

   See if you can join NCT06853665 on ClinicalTrials.gov

4. Oxytocin Effects on Bone in Children With Autism Spectrum Disorder

   This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin on bone health in children with autism spectrum disorder, ages 6-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (30 IU, 2 times daily) for 12 months in the double-…

   Stage

   Phase 2

   Ages

   6 to 18

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Elizabeth Austen Lawson

   See if you can join NCT05754073 on ClinicalTrials.gov

5. AWARE: Management of ADHD in Autism Spectrum Disorder

   This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will…

   Stage

   Phase 4

   Ages

   4 to 17

   Site

   Massachusetts General Hospital Lurie Center for Autism, Boston, Massachusetts

   Locations

   12 in total

   Run by

   Daniel Coury

   See if you can join NCT05916339 on ClinicalTrials.gov